1Steyn, K. A policy proposal to manage chronic diseases of lifestyle in South Africa. S. Afr. Med. J. 1992; 82: 220–1.
2Popkin, BM. The nutrition transition in low-income countries: an emerging crisis. Nutr. Rev. 1994; 52: 285–98.
3Wilhelmsen, L, Svärdsudd, K, Korsan-Bengsten, K, Larsson, B. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 1984; 311: 5001–505.
4Meade, TW, Brozovic, M, Charkrabarti, RR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533–7.
5Kannel, WB, Wolf, PA, Castelli, WP. D'Agostino, RB. Fibrinogen and risk of cardiovascular disease. J. Am. Med. Assoc. 1987; 258: 1183–6.
6Yarnell, IWG, Fehilly, AM, Milbank, J, Kubicki, AJ. Eastham, R, Haynes, TM. Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales. J. Epidemiol. Comm. Health. 1983; 37: 137–40.
7Assman, G, Schulte, H. Results and conclusions of the prospective cardiovascular Münster (PROCAM) Study. In: Asmann, G, ed. Lipid Metabolism Disorders and Coronary Heart Disease. Munich: MMV Medizin Verlag, 1993: 19–67.
8Folsom, AR, Wu, KK, Conlan, MG. Fibrinogen and cardiovascular risk in the atherosclerosis risk in communities (ARIC) study. In: Ernst, E, Koenig, W, Lowe, GDO, Mcade, TW. eds. Fibrinogen: a ‘New’ Cardiovascular Risk Factor. Vienna: Blackwell-MZV, 1992: 124–9.
9Erikson, H, Wilhelmsen, L, Welin, L, Larsson, B, Svärdsudd, , Tibblin, G. 21-year follow-up of CVD and total mortality among men born in 1913. In: Ernst, E, Koenig, W, Lowe, GDO, Meade, TW, eds. Fibrinogen: a ‘New’ Cardiorvascular Risk Factor. Vienna: Blackwell-MZV, 1992: 115–19.
10Tarallo, P, Henny, J, Gueguen, R, Siest, G. Reference limits of plasma fibrinogen. Eur. J. Clin. Chem. Clin. Biochem. 1992; 30: 745–51.
11Folsom, AR, Wu, KK, Davis, CE, Conlan, MG, Sorlie, PD, Szklo, M. Population correlates of plasma fibrinogen and factor VII. purative cardiovascular risk factors. Atherosclerosis 1991; 91: 191–205.
12Lee, AJ, Smith, WCS, Lowe, GDO. Tunstall-Pedoe, H. Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J. Clin. Epidemiol. 1990; 43: 913–19.
13Cook, NS, Ubben, D. Fibrinogen as a major risk factor in cardiovascular disease. Trends Pharm. Sci. 1990; 11: 444–51.
14Humphries, SE, Cook, M, Dubowitz, M, Stirling, Y, Meade, TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen. Lancet 1987; 1: 1452–55.
15Ernst, E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1–12.
16Iso, H, Folsom, AR. Sato, S, et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscl. Thromb. 1993; 13: 783–90.
17Venter, CS, Vorster, HH. Silvis, A. Mia, F. Seftel, HC. Determinants of plasma fibrinogen levels in South African communites. In: Ernst, E, Koenig, W. Low, CDO, Meade, TW. eds. Fibrinogen: a ‘New‚ Cardiovacular Risk Factor. Vienna: Blackwell-MZV. 1992: 166–71.
18Steyn, K. Fourie, J, eds. BRISK Study Methodology. Coronary Heart Disease Risk Factor Study in the African Population of the Cape Peninsula. Technical report no. I. Medical Research Council, Parow, 1991: 1–44.
19Steyn, K, Jooste, PL, Bourne, L, et al. Risk factors for coronary heart disease in the black population of the Cape Peninsula. S. Afr. Med. J. 1991; 79: 480–5.
20Osterud, B. How to measure factor VII and factor VII activation. Haemostasis 1983; 13: 161–8.
21Stat Soft Incorporated. Complete Statistical System (CCS). Stat Soft Inc. 1991, Tulsa, OK 74104.
22Møller, L. Kristensen, TS. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler. Thromb. 1991; 11: 344–50.
23Balleisen, L, Bailey, J, Epping, PH, Schulte, H, Van de Loo, J. Epidemiological study on factor VII, factor VIlI and fibrinogen in an industrial population I. Thromb. Hemost. 1985; 54: 475.
24Farinaro, E. Prevention of coronary heart disease: scientific background and new clinical guidelines. In: Asmann, G. ed. Lipid Metabolism isorders and Coronary Heart Disease. Munich: MMV Medizin Verlag, 1993: 69–139.
25Vorster, HH, Venter, CS. Fibrinogen as risk factor for coronary heart disease. Cardiovasc. J. S. Afr. 1994; 5: 117–24.
26Kannel, WB. CHD risk factors: a Framingham Study update. Hosp. Pract. 1990; 25: 119–27.
27Luria, MH, Erel, J, Sapoznikov, D, Gotsman, MS. Cardiovascular risk factor clustering and ratio of total cholesterol to high-density lipoprotein cholesterol in angiographically documented coronary artery disease. Am. J. Cardiol. 1991; 67: 131–6.
28Ernst, E. Oral contraceptives, fibrinogen and cardiovascular risk. Atherosclerosis 1992; 93: 1–5.
29Walker, ARP, Adam, A, Kustner, HGV. Changes in total death rate and in ischaemic heart disease death rate in interethnic South African populations. S. Afr. Med. J. 1993; 83: 602–5.
30Sherman, AJ. Coronary heart disease in black Americans; suggestions for research on psychosocial factors. Am. Heart. J. 1984; 3: 833–8.
31Vermaak, WJH. Ubbink, JB, Delport, R, Becker, PJ, Bissbort, SH, Ungerer, JPJ. Ethnic immunity to coronary heart disease? Atherosclerosis 1991; 89: 155–62.
32Franz, RC, Meiring, JL. Coetzee, WJC. Ethnic differences in the haemostatic, fibrinolytic and lipographic patterns. S. Afr. J. Surg. 1980; 18: 58–9.
33Jerling, JC, Vorster, HH, Oosthuzen, W, Silvis, N, Venter, CS. Differences in plasminogen activator inhibitor I activity between blacks and whites may be diet related. Haemostusis 1993; 24: 364–8.
34Wyndham, CH. Mortality from cardiovascular diseases in the various population groups in the Republic of South Africa. S. Afr Med. J. 1979; 56: 1023–30.
35Joubert, J. The MEDUNSA Stroke Data Bank. An analysis of 304 patients seen between 1986 and 1987. S. Afr. Med. J. 1991; 80: 567–70.
36Broderick, JP, Brott, T, Tomsick, T, Huster, G, Miller, R. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N. Engl. J. Med. 1992; 326: 733–6.
37Kittner, SJ, White, LR, Losonczy, KG, Wolf, PA, Hebel, JR. Black-white differences in stroke incidence in a national sample. J. Am. Med. Assoc. 1990; 264: 1267–70.
38Gaines, KJ, Chesney, C, Van der Zwaag, R, Cape, C. Racial differences in coagulation studies in stroke. Neurol. Res. 1992; 14: 103–8.
39Carter, LR, Walton, SE, Knowles, MK, Wing, S, Tyroler, HA. Social inequality of stroke mortality among US black populations, 1968 to 1987. Ethn. Dis. 1992; 2: 343–51.
40Casper, M, Wing, S, Strogatz, D. Variation in the magnitude of black - white differences in stroke mortality by community occupational structure. J. Epidemiol. Comm. Health 1991; 45: 302–6.
41Markowe, HLJ. Marmot, MG, Shipley, MJ, et al. Fibrinogen: a possible link between social class and coronary heart disease. Br. Med. J. 1985; 291: 1312–14.
42Netterstrøm, B, Søndergård, k, Damsgaard, MT, Olsen, O, Sjøl, A. Job strain and cardiovascular risk factors; a cross sectional study of employed Danish men and women. Br. J. Ind. Med. 1991; 48: 584–689.